| Expression System | HEK293 |
|---|
| Protein Tag | No tag |
|---|
| Purity | > 95% by SDS-PAGE under reducing conditions |
|---|
| Endotoxin | < 0.1 EU per ug by the LAL method |
|---|
| Activity | Positive |
|---|
| Conjugate | Unconjugated |
|---|
| Species | Human |
|---|
| Accession Number | AAH93628.1 |
|---|
| Protein Sequence | Ala28-Arg193 |
|---|
| Molecular Weight | The protein has a predicted molecular weight of 19kDa and migrates at approximately 35-45kDa on SDS-PAGE with DTT-reduced condition. |
|---|
| Formulation | Lyophilized powder from 0.22um filtered solution in PBS, pH 7.4, 8% trehalose |
|---|
| Purification | SEC |
|---|
| Applications | ELISA |
|---|
| Format | Lyophilized |
|---|
| Reconstitution | Centrifuge the tube before opening. Recommend reconstitute to a concentration > 100 ug/ml |
|---|
| Shipping Condition | Ambient |
|---|
| Storage/Shelf Life | <-20 °C for 12 months from the date of receipt; -80°C for 3 months after reconstitution. |
|---|
| Background Information | Human Erythropoietin (EPO) is a glycoprotein hormone primarily produced by the kidneys, and to a lesser extent by the liver, that regulates red blood cell production (erythropoiesis). EPO stimulates the bone marrow to produce more red blood cells in response to low oxygen levels or other factors that trigger the process. |
|---|
| figure legend1 | Human EPO protein on SDS-PAGE under reducing condition (P+). The purity of this protein appears to be greater than 95%. |
|---|
| figure legend2 | Human EPO protein is coated at 1ug/ml (100ul/well) on the plate. Human EPO receptor protein can bind Human EPO protein in the dose dependent manner. The EC50 is about 30ng/ml. |
|---|
| country of manufacture | USA |
|---|
| HazMat y/n | N |
|---|
